The DEA Finally Decides To Reschedule Hydrocodone
Posted on August 27, 2014 by Tower MSA Partners
Last week the DEA released a final rule on the rescheduling of hydrocodone removing it from the schedule III controlled substances list in favor of a schedule II designation. To be clear, this decision specifically addresses hydrocodone combination products (i.e.,…
For Media Inquires, Contact:
Helen King Patterson
813.690.4787
helen@kingknight.com
Search our blog:
Contact Us for a FREE Consultation